This video was created in 2016 and features Mark Skeen, MD, Associate Professor of Neurology at Duke University School of Medicine. Please visit www.nationalMSsociety.org/meds for the most updated information. To learn more about Natalizumab and other disease modifying therapy options, download the Consensus on Disease Modifying Therapies online at www.nationalmssociety.org/DMTconsensus.
Негізгі бет What You Need to Know About Natalizumab (Tysabri®)
Пікірлер: 28